Chemistry & Biochemistry
-
Dave Kliger stepping down as CP/EVC on Sept. 16
Dave Kliger is eager to return to the lab after he steps down as campus provost/executive vice chancellor on September 16.
-
Local group funds UCSC cancer researchers
The Santa Cruz Cancer Benefit Group, a local charity supporting cancer research and patient care, has awarded grants of $10,000 each to three researchers at UCSC.
-
Protein structure reveals how tumor suppressor turns on and off
The retinoblastoma tumor suppressor protein acts like a gate in the cycle of cell growth and division–a gate that stays open in many types of cancer, allowing cells to multiply out of control.
-
Composite nanomaterials show promise for solar hydrogen generation
A novel strategy for engineering semiconductor materials can boost the performance of water-splitting solar cells for hydrogen production.
-
Three UCSC professors elected 2009 AAAS Fellows
Three professors at the University of California, Santa Cruz, have been awarded the distinction of AAAS Fellow by the American Association for the Advancement of Science.
-
Chemist Jin Zhang elected Fellow of American Physical Society
Jin Zhang, professor of chemistry and biochemistry, has been elected a Fellow of the American Physical Society in recognition of his outstanding contributions to physics.
-
Chemistry professor Phil Crews receives outstanding faculty award
Phillip Crews, professor of chemistry and biochemistry, has received the 2008-09 Outstanding Faculty Award from the Division of Physical and Biological Sciences.
-
UCSC arts and science faculty collaborate for exhibition at Sesnon Gallery
“Full Disclosure”–an exhibition opening on October 7 at UCSC’s Sesnon Gallery-is built upon the idea of “failure” as a path to learning.
-
Five faculty members win 2009 NSF CAREER awards
Five UCSC faculty members have won NSF CAREER awards in 2009.
-
Academic program for community college students wins extended NIH funding
A UCSC program that provides an academic bridge for community college students has received a $1.1 million grant from the NIH.
-
Novel light-sensitive compounds show promise for cancer therapy
Novel compounds show promise for photodynamic cancer therapy, which uses light-activated drugs to kill tumor cells.
